CELZ (Creative Medical Technology Holdings) Cash-to-Debt : No Debt ⁽¹⁾ (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Creative Medical Technology Holdings's cash to debt ratio for the quarter that ended in Dec. 2024 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Creative Medical Technology Holdings could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Creative Medical Technology Holdings's Cash-to-Debt or its related term are showing as below:

CELZ' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 1.73 Max: No Debt
Current: No Debt

During the past 13 years, Creative Medical Technology Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 0.03. And the median was 1.73.

CELZ's Cash-to-Debt is ranked better than
99.87% of 1488 companies
in the Biotechnology industry
Industry Median: 7.4 vs CELZ: No Debt

Creative Medical Technology Holdings Cash-to-Debt Historical Data

The historical data trend for Creative Medical Technology Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Creative Medical Technology Holdings Cash-to-Debt Chart

Creative Medical Technology Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

Get a 7-Day Free Trial

0.12

No Debt

Creative Medical Technology Holdings Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	No Debt	No Debt	No Debt	No Debt

Competitive Comparison of Creative Medical Technology Holdings's Cash-to-Debt

For the Biotechnology subindustry, Creative Medical Technology Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creative Medical Technology Holdings's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's Cash-to-Debt falls into.

Creative Medical Technology Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Creative Medical Technology Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Creative Medical Technology Holdings had no debt ⁽¹⁾.

Creative Medical Technology Holdings's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Creative Medical Technology Holdings had no debt ⁽¹⁾.

Creative Medical Technology Holdings (NAS:CELZ) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Creative Medical Technology Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Creative Medical Technology Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

211 E Osborn Road, Phoenix, AZ, USA, 85012

Website

https://www.creativemedicaltechnology.com

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Executives

Michael H. Finger	director	1551 N. DIANE ST., MESA AZ 85203-3850
Timothy Warbington	director, 10 percent owner, officer: President & CEO	211 E. OSBORN ROAD, PHOENIX AZ 85012
Susan H Snow	director	26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang	director	5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim	director	211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc.	10 percent owner	211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst	10 percent owner	2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel	director	1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson	director, officer: CFO & Sr.VP	822 VERA STREET, SOLANA BEACH CA 92075
Steven L White	director, officer: President,Secretary,Treasurer	386 NORTH 210 EAST, MAPLETON UT 84664